A Phase 3 Study of Ibrutinib (PCI-32765) Versus Ofatumumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT01578707 · COMPLETED
Trial details
- NCT number
- NCT01578707
- Sponsor
- Pharmacyclics LLC.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2013-11-01
- Enrollment
- 391
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.